In 2005, Crotti et al. demonstrated that the p.K897T_KCNH2 (MAF = 0.1871) polymorphism can act as a genetic modifier of LQTS clinical severity in the presence of other rare variants in the same gene. Here, KCNH2 is linked to familial long QT syndrome.